HTR6 and Alzheimer disease: Although this intrinsic activity does not define clear preferences for potential therapeutic actions, as procognitive, antidepressant-like and anxiolytic effects in animal models were confirmed either for agonists or antagonists, the 5-HT6R antagonists are of greater interest to researchers; 17 have reached clinical trials, including 6 towards AD [22].